Development of a reactive stroma associated with prostatic intraepithelial neoplasia in EAF2 deficient mice

Laura E Pascal1, Junkui Ai, Khalid Z Masoodi

  • 1Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America.

Plos One
|November 22, 2013
PubMed

Insights

Loss of ELL-associated factor 2 (EAF2) in mice causes prostate lesions with reactive stroma and increased blood vessels, mirroring human prostate cancer. EAF2 deficiency impacts androgen deprivation response and is linked to tumor progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • ELL-associated factor 2 (EAF2) is an androgen-responsive tumor suppressor crucial for RNA Pol II transcription elongation.
  • EAF2 deletions are common in advanced prostate cancer.
  • Previous studies showed EAF2 knockout mice develop various cancers, including prostatic intraepithelial neoplasia (PIN).

Purpose of the Study:

  • To investigate the role of EAF2 in prostate defect development across different mouse genetic backgrounds.
  • To characterize the stromal and microvascular changes associated with EAF2 loss in the prostate.
  • To compare EAF2's role in mouse models with its expression and microvessel density in human prostate cancer.

Main Methods:

  • Comparison of EAF2 knockout (EAF2(-/-)) mice on C57BL/6J, FVB/NJ, and 129P2/OLA-C57BL/6J backgrounds.
  • Histological analysis of prostate tissues to identify lesions, stromal defects, and microvessel density.
  • Assessment of EAF2-deficient mice's response to androgen deprivation.
  • Analysis of EAF2 expression and microvessel density in human prostate cancer tissues.

Main Results:

  • Aged EAF2(-/-) mice on C57BL/6J and FVB/NJ backgrounds developed mPIN lesions, similar to those on a mixed background.
  • Prostatic lesions in C57BL/6J and FVB/NJ EAF2(-/-) mice showed reactive stromal defects and significantly increased prostate microvessel density.
  • Stromal inflammation and increased microvessel density preceded epithelial hyperplasia and neoplasia in EAF2-deficient mice.
  • EAF2 deficiency led to increased recovery and decreased response to androgen deprivation.
  • Human prostate cancer tissues exhibited down-regulated EAF2 expression and increased microvessel density compared to normal tissues, with a negative correlation between EAF2 expression and microvessel density.

Conclusions:

  • EAF2 knockout mice on C57BL/6J and FVB/NJ backgrounds serve as a valuable model for studying PIN lesions associated with altered prostate microvasculature and reactive stroma.
  • These findings highlight EAF2's role in maintaining prostate homeostasis and its potential as a therapeutic target in prostate cancer.

Related Concept Videos